John R. Carr

John R. Carr

Auto-generated profile, based on publicly available information

John R. Carr

St. Joseph's/Candler Savannah Georgia USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2019 in Journal of Pharmacy Practice
Verified
Journal Article
Open access
PDF file
WHW. Anthony Hawkins
W. Anthony Hawkins
SSSusan E. Smith
Susan E. Smith
ANAndrea Newsome
Andrea Newsome
JCJohn R. Carr
John R. Carr
Christopher M. BlandChristopher M. Bland
Christopher M. Bland
TBTrisha N. Branan
Trisha N. Branan
Intravenous fluids (IVFs) are the most common drugs administered in the intensive care unit. Despite the ubiquitous use, IVFs are not benign and carry significant risks associated with under- or overadministration. Hypovolemia is associated with decreased organ perfusion, ischemia, and multi-organ failure. Hypervolemia and volume overload are associated with organ dysfunction, delayed liberation from mechanical ventilation, and increased mortality. Despite appropriate provision of IVF, adverse drug effects such as electrolyte abnormalities and acid–base disturbances may occur. The management of volume status in critically ill patients is both dynamic and tenuous, a process that requires frequent monitoring and high clinical acumen. Because patient-specific considerations for fluid therapy evolve across the continuum of critical illness, a standard approach to the assessment of fluid needs and prescription of IVF therapy is necessary. We propose the principle of “fluid stewardship,” guided by 4 rights of medication safety: right patient, right drug, right route, and right dose. The successful implementation of fluid stewardship will aid pharmacists in making decisions regarding IVF therapy to optimize hemodynamic management and improve patient outcomes. Additionally, we highlight several areas of focus for future research, guided by the 4 rights construct of fluid stewardship.

8 April 2021 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
JCJohn R. Carr
John R. Carr
WHW. Anthony Hawkins
W. Anthony Hawkins
ANAndrea Newsome
Andrea Newsome
SSSusan E. Smith
Susan E. Smith
CBClemmons Amber B
Clemmons Amber B
O(on behalf of The University of Georgia College of Pharmacy Critical Care Collaborative (UGAC3).
on behalf of The University of Georgia College of Pharmacy Critical Care Collaborative (UGAC3).
Despite the frequent use of maintenance intravenous fluids (mIVF) in critically ill patients, limited guidance is available. Notably, fluid overload secondary to mIVF mismanagement is associated with significant adverse patient outcomes. The Four Rights (right drug, right dose, right duration, right patient) construct of fluid stewardship has been proposed for the safe evaluation and use of fluids. The purpose of this evidence-based review is to offer practical insights for the clinician regarding mIVF selection, dosing, and duration in line with the Four Rights of Fluid Stewardship.

12 January 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
JCJohn R. Carr
John R. Carr
SSSusan E. Smith
Susan E. Smith


5 November 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
JCJohn R. Carr
John R. Carr
Christopher M. BlandChristopher M. Bland
Christopher M. Bland

8 November 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
JCJohn Carr
John Carr
SWShelby Wathen
Shelby Wathen
APAbigail Powell
Abigail Powell
CBChloe Baskowitz
Chloe Baskowitz
HDHuong Duong
Huong Duong
SSSusan E. Smith
Susan E. Smith
Background: Delirium is among the most common neurological complications in intensive care unit ( ICU ) patients, yet many medication‐related contributors remain poorly understood. As medication experts, pharmacists are uniquely positioned to lead efforts in identifying, mitigating, and preventing drug‐related risk factors for delirium. One underexplored risk factor is the frequency of medication‐related skin punctures. The purpose of this study was to evaluate the association between ICU delirium and the number of medication‐related skin punctures, with the goal of identifying potential pharmacist‐driven interventions to reduce delirium as well as improve patient experience and outcomes. Methods: This was a retrospective, observational, exploratory cohort study conducted in the ICU of a 384‐bed community hospital. Patients were divided into two groups, low‐punctures and high‐punctures, using the median number of skin punctures per day as the threshold for defining groups. The primary outcome was the incidence of delirium. Secondary outcomes were delirium‐free days, all‐cause mortality, hospital length of stay ( LOS ), and ICU LOS . Results: A total of 404 patients were included in this study. The median number of medication‐related skin punctures was 3.79 per day. There were 205 patients in the low‐punctures group (0 to less than 4 punctures per day) and 199 patients in the high‐punctures group (at least 4 punctures per day). The high‐punctures group was associated with increased odds of delirium (odds ratio [ OR ] 2.09, 95% confidence interval [ CI ] 1.22–3.58, p = 0.007). There was no significant difference in delirium‐free days, hospital LOS , and all‐cause mortality between groups; however, ICU LOS was significantly longer in the high‐punctures group (7 vs. 5 days, p < 0.001). Conclusion: The frequency of medication‐related skin punctures ICU patients received may be associated with an increased risk of delirium. These exploratory findings support future research evaluating the impact of pharmacist‐driven “skin puncture stewardship” on ICU delirium prevention, patient experience, and overall clinical outcomes.